 | • レポートコード：QYR9ST01162 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の関節リウマチ薬市場について調査・分析し、以下の構成でお届け致します。関節リウマチ薬の種類別には、処方薬、市販薬に、用途別には、病院、クリニック、老人ホーム、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別関節リウマチ薬売上データ ・地域別関節リウマチ薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別関節リウマチ薬市場規模：処方薬、市販薬 ・用途別関節リウマチ薬市場規模：病院、クリニック、老人ホーム、その他 ・主要メーカーの企業情報：AbbVie、Amgen、Bayer、Biogen、Boehringer Ingelheim、Bristol-Myers Squibb、F. Hoffmann-La Roche、Johnson and Johnson、Merck、Mitsubishi Tanabe Pharma、Novartis、Pfizer、UCB S.A ・関節リウマチ薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Rheumatoid Arthritis Drugs include prescription and OTC.The increasing prevalence of arthritis, the increasing acceptance of biopharmaceuticals, and the development of clear regulatory guidelines are major trends that are expected to trigger market growth.
The global Rheumatoid Arthritis Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Rheumatoid Arthritis Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Rheumatoid Arthritis Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Rheumatoid Arthritis Drugs in these regions.
This research report categorizes the global Rheumatoid Arthritis Drugs market by top players/brands, region, type and end user. This report also studies the global Rheumatoid Arthritis Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie
Amgen
Bayer
Biogen
Boehringer Ingelheim
Bristol-Myers Squibb
F. Hoffmann-La Roche
Johnson and Johnson
Merck
Mitsubishi Tanabe Pharma
Novartis
Pfizer
UCB S.A
Market size by Product
Prescription Drugs
Over-the-counter Drugs
Market size by End User
Hospital
Clinic
Nursing home
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Rheumatoid Arthritis Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Rheumatoid Arthritis Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Rheumatoid Arthritis Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Rheumatoid Arthritis Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Rheumatoid Arthritis Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Rheumatoid Arthritis Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Rheumatoid Arthritis Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Rheumatoid Arthritis Drugs Market Size Growth Rate by Product
1.4.2 Prescription Drugs
1.4.3 Over-the-counter Drugs
1.5 Market by End User
1.5.1 Global Rheumatoid Arthritis Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Nursing home
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rheumatoid Arthritis Drugs Market Size
2.1.1 Global Rheumatoid Arthritis Drugs Revenue 2014-2025
2.1.2 Global Rheumatoid Arthritis Drugs Sales 2014-2025
2.2 Rheumatoid Arthritis Drugs Growth Rate by Regions
2.2.1 Global Rheumatoid Arthritis Drugs Sales by Regions
2.2.2 Global Rheumatoid Arthritis Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Rheumatoid Arthritis Drugs Sales by Manufacturers
3.1.1 Rheumatoid Arthritis Drugs Sales by Manufacturers
3.1.2 Rheumatoid Arthritis Drugs Sales Market Share by Manufacturers
3.1.3 Global Rheumatoid Arthritis Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Rheumatoid Arthritis Drugs Revenue by Manufacturers
3.2.1 Rheumatoid Arthritis Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Rheumatoid Arthritis Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Rheumatoid Arthritis Drugs Price by Manufacturers
3.4 Rheumatoid Arthritis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Rheumatoid Arthritis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rheumatoid Arthritis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Rheumatoid Arthritis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Rheumatoid Arthritis Drugs Sales by Product
4.2 Global Rheumatoid Arthritis Drugs Revenue by Product
4.3 Rheumatoid Arthritis Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Rheumatoid Arthritis Drugs Breakdown Data by End User
6 North America
6.1 North America Rheumatoid Arthritis Drugs by Countries
6.1.1 North America Rheumatoid Arthritis Drugs Sales by Countries
6.1.2 North America Rheumatoid Arthritis Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Rheumatoid Arthritis Drugs by Product
6.3 North America Rheumatoid Arthritis Drugs by End User
7 Europe
7.1 Europe Rheumatoid Arthritis Drugs by Countries
7.1.1 Europe Rheumatoid Arthritis Drugs Sales by Countries
7.1.2 Europe Rheumatoid Arthritis Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rheumatoid Arthritis Drugs by Product
7.3 Europe Rheumatoid Arthritis Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Rheumatoid Arthritis Drugs by Countries
8.1.1 Asia Pacific Rheumatoid Arthritis Drugs Sales by Countries
8.1.2 Asia Pacific Rheumatoid Arthritis Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Rheumatoid Arthritis Drugs by Product
8.3 Asia Pacific Rheumatoid Arthritis Drugs by End User
9 Central & South America
9.1 Central & South America Rheumatoid Arthritis Drugs by Countries
9.1.1 Central & South America Rheumatoid Arthritis Drugs Sales by Countries
9.1.2 Central & South America Rheumatoid Arthritis Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Rheumatoid Arthritis Drugs by Product
9.3 Central & South America Rheumatoid Arthritis Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Rheumatoid Arthritis Drugs by Countries
10.1.1 Middle East and Africa Rheumatoid Arthritis Drugs Sales by Countries
10.1.2 Middle East and Africa Rheumatoid Arthritis Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Rheumatoid Arthritis Drugs by Product
10.3 Middle East and Africa Rheumatoid Arthritis Drugs by End User
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 Company Business Overview
11.1.3 AbbVie Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AbbVie Rheumatoid Arthritis Drugs Products Offered
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Company Business Overview
11.2.3 Amgen Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Amgen Rheumatoid Arthritis Drugs Products Offered
11.2.5 Amgen Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Business Overview
11.3.3 Bayer Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Bayer Rheumatoid Arthritis Drugs Products Offered
11.3.5 Bayer Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Company Business Overview
11.4.3 Biogen Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Biogen Rheumatoid Arthritis Drugs Products Offered
11.4.5 Biogen Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Business Overview
11.5.3 Boehringer Ingelheim Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Boehringer Ingelheim Rheumatoid Arthritis Drugs Products Offered
11.5.5 Boehringer Ingelheim Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Company Business Overview
11.6.3 Bristol-Myers Squibb Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Bristol-Myers Squibb Rheumatoid Arthritis Drugs Products Offered
11.6.5 Bristol-Myers Squibb Recent Development
11.7 F. Hoffmann-La Roche
11.7.1 F. Hoffmann-La Roche Company Details
11.7.2 Company Business Overview
11.7.3 F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Products Offered
11.7.5 F. Hoffmann-La Roche Recent Development
11.8 Johnson and Johnson
11.8.1 Johnson and Johnson Company Details
11.8.2 Company Business Overview
11.8.3 Johnson and Johnson Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Johnson and Johnson Rheumatoid Arthritis Drugs Products Offered
11.8.5 Johnson and Johnson Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Company Business Overview
11.9.3 Merck Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Merck Rheumatoid Arthritis Drugs Products Offered
11.9.5 Merck Recent Development
11.10 Mitsubishi Tanabe Pharma
11.10.1 Mitsubishi Tanabe Pharma Company Details
11.10.2 Company Business Overview
11.10.3 Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Products Offered
11.10.5 Mitsubishi Tanabe Pharma Recent Development
11.11 Novartis
11.12 Pfizer
11.13 UCB S.A
12 Future Forecast
12.1 Rheumatoid Arthritis Drugs Market Forecast by Regions
12.1.1 Global Rheumatoid Arthritis Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Rheumatoid Arthritis Drugs Revenue Forecast by Regions 2019-2025
12.2 Rheumatoid Arthritis Drugs Market Forecast by Product
12.2.1 Global Rheumatoid Arthritis Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Rheumatoid Arthritis Drugs Revenue Forecast by Product 2019-2025
12.3 Rheumatoid Arthritis Drugs Market Forecast by End User
12.4 North America Rheumatoid Arthritis Drugs Forecast
12.5 Europe Rheumatoid Arthritis Drugs Forecast
12.6 Asia Pacific Rheumatoid Arthritis Drugs Forecast
12.7 Central & South America Rheumatoid Arthritis Drugs Forecast
12.8 Middle East and Africa Rheumatoid Arthritis Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rheumatoid Arthritis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Rheumatoid Arthritis Drugs Product Picture
Table Rheumatoid Arthritis Drugs Market Segments
Table Key Manufacturers Rheumatoid Arthritis Drugs Covered
Table Global Rheumatoid Arthritis Drugs Market Size Growth Rate by Product 2019-2025 (MT) & (Million US$)
Figure Global Rheumatoid Arthritis Drugs Sales Market Share by Product 2014-2025
Figure Prescription Drugs Product Picture
Table Major Manufacturers of Prescription Drugs
Figure Over-the-counter Drugs Product Picture
Table Major Manufacturers of Over-the-counter Drugs
Table Global Rheumatoid Arthritis Drugs Market Size Growth Rate by End User 2019-2025 (MT)
Figure Hospital
Figure Clinic
Figure Nursing home
Figure Other
Figure Rheumatoid Arthritis Drugs Report Years Considered
Figure Global Rheumatoid Arthritis Drugs Market Size 2014-2025 (Million US$)
Figure Global Rheumatoid Arthritis Drugs Sales 2014-2025 (MT)
Table Global Rheumatoid Arthritis Drugs Market Size by Regions 2014-2019 (MT) & (Million US$)
Table Global Rheumatoid Arthritis Drugs Sales by Regions 2014-2019 (MT)
Table Global Rheumatoid Arthritis Drugs Sales Market Share by Regions 2014-2019
Figure Global Rheumatoid Arthritis Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Rheumatoid Arthritis Drugs Sales Market Share by Regions
Table Global Rheumatoid Arthritis Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Rheumatoid Arthritis Drugs Revenue Market Share by Regions 2014-2019
Figure Global Rheumatoid Arthritis Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Rheumatoid Arthritis Drugs Revenue Market Share by Regions
Table Global Rheumatoid Arthritis Drugs Sales by Manufacturers (2014-2019) (MT)
Table Global Rheumatoid Arthritis Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Rheumatoid Arthritis Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Rheumatoid Arthritis Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Rheumatoid Arthritis Drugs Revenue Share by Manufacturers (2014-2019)
Figure Rheumatoid Arthritis Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Rheumatoid Arthritis Drugs Price (2014-2019) (USD/Kg)
Table Rheumatoid Arthritis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Rheumatoid Arthritis Drugs Product Type
Table Date of International Manufacturers Enter into Rheumatoid Arthritis Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Rheumatoid Arthritis Drugs Sales by Product (2014-2019) (MT)
Table Global Rheumatoid Arthritis Drugs Sales Share by Product (2014-2019)
Figure Global Rheumatoid Arthritis Drugs Sales Market Share by Product (2014-2019)
Figure Global Rheumatoid Arthritis Drugs Sales Market Share by Product in 2018
Table Global Rheumatoid Arthritis Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Rheumatoid Arthritis Drugs Revenue Share by Product (2014-2019)
Figure Global Rheumatoid Arthritis Drugs Revenue Market Share by Product (2014-2019)
Figure Global Rheumatoid Arthritis Drugs Revenue Market Share by Product in 2018
Table Rheumatoid Arthritis Drugs Price by Product 2014-2019 (USD/Kg)
Table Global Rheumatoid Arthritis Drugs Sales by End User (2014-2019) (MT)
Table Global Rheumatoid Arthritis Drugs Sales Share by End User (2014-2019)
Figure Global Sales Rheumatoid Arthritis Drugs Market Share by End User (2014-2019)
Figure Global Sales Rheumatoid Arthritis Drugs Market Share by End User in 2018
Figure North America Rheumatoid Arthritis Drugs Sales Growth Rate 2014-2019 (MT)
Figure North America Rheumatoid Arthritis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Rheumatoid Arthritis Drugs Sales by Countries (2014-2019) (MT)
Table North America Rheumatoid Arthritis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Rheumatoid Arthritis Drugs Sales Market Share by Countries
Table North America Rheumatoid Arthritis Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Rheumatoid Arthritis Drugs Revenue Market Share by Countries
Figure United States Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure United States Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (MT)
Figure Canada Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Canada Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Mexico Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Rheumatoid Arthritis Drugs Sales by Product (2014-2019) (MT)
Table North America Rheumatoid Arthritis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Rheumatoid Arthritis Drugs Market Share by Product
Table North America Rheumatoid Arthritis Drugs Sales by End User (2014-2019) (MT)
Table North America Rheumatoid Arthritis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Rheumatoid Arthritis Drugs Market Share by End User
Figure Europe Rheumatoid Arthritis Drugs Sales Growth Rate 2014-2019 (MT)
Figure Europe Rheumatoid Arthritis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Rheumatoid Arthritis Drugs Sales by Countries (2014-2019) (MT)
Table Europe Rheumatoid Arthritis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Rheumatoid Arthritis Drugs Sales Market Share by Countries
Table Europe Rheumatoid Arthritis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Rheumatoid Arthritis Drugs Revenue Market Share by Countries
Figure Germany Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Germany Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure France Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure UK Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Italy Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Russia Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Rheumatoid Arthritis Drugs Sales by Product (2014-2019) (MT)
Table Europe Rheumatoid Arthritis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Rheumatoid Arthritis Drugs Market Share by Product
Table Europe Rheumatoid Arthritis Drugs Sales by End User (2014-2019) (MT)
Table Europe Rheumatoid Arthritis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Rheumatoid Arthritis Drugs Market Share by End User
Figure Asia Pacific Rheumatoid Arthritis Drugs Sales Growth Rate 2014-2019 (MT)
Figure Asia Pacific Rheumatoid Arthritis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Rheumatoid Arthritis Drugs Sales by Countries (2014-2019) (MT)
Table Asia Pacific Rheumatoid Arthritis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Rheumatoid Arthritis Drugs Sales Market Share by Countries
Table Asia Pacific Rheumatoid Arthritis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Rheumatoid Arthritis Drugs Revenue Market Share by Countries
Figure China Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure China Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Japan Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Korea Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure India Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Australia Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Indonesia Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Malaysia Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Philippines Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Thailand Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Vietnam Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Singapore Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Rheumatoid Arthritis Drugs Sales by Product (2014-2019) (MT)
Table Asia Pacific Rheumatoid Arthritis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Rheumatoid Arthritis Drugs Market Share by Product
Table Asia Pacific Rheumatoid Arthritis Drugs Sales by End User (2014-2019) (MT)
Table Asia Pacific Rheumatoid Arthritis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Rheumatoid Arthritis Drugs Market Share by End User
Figure Central & South America Rheumatoid Arthritis Drugs Sales Growth Rate 2014-2019 (MT)
Figure Central & South America Rheumatoid Arthritis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Rheumatoid Arthritis Drugs Sales by Countries (2014-2019) (MT)
Table Central & South America Rheumatoid Arthritis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Rheumatoid Arthritis Drugs Sales Market Share by Countries
Table Central & South America Rheumatoid Arthritis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Rheumatoid Arthritis Drugs Revenue Market Share by Countries
Figure Brazil Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Brazil Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Argentina Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Rheumatoid Arthritis Drugs Sales by Product (2014-2019) (MT)
Table Central & South America Rheumatoid Arthritis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Rheumatoid Arthritis Drugs Market Share by Product
Table Central & South America Rheumatoid Arthritis Drugs Sales by End User (2014-2019) (MT)
Table Central & South America Rheumatoid Arthritis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Rheumatoid Arthritis Drugs Market Share by End User
Figure Middle East and Africa Rheumatoid Arthritis Drugs Sales Growth Rate 2014-2019 (MT)
Figure Middle East and Africa Rheumatoid Arthritis Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Rheumatoid Arthritis Drugs Sales by Countries (2014-2019) (MT)
Table Middle East and Africa Rheumatoid Arthritis Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Rheumatoid Arthritis Drugs Sales Market Share by Countries
Table Middle East and Africa Rheumatoid Arthritis Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Rheumatoid Arthritis Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Rheumatoid Arthritis Drugs Revenue Market Share by Countries
Figure GCC Countries Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure GCC Countries Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Turkey Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure Egypt Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Rheumatoid Arthritis Drugs Sales Growth Rate (2014-2019) (MT)
Figure South Africa Rheumatoid Arthritis Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Rheumatoid Arthritis Drugs Sales by Product (2014-2019) (MT)
Table Middle East and Africa Rheumatoid Arthritis Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Rheumatoid Arthritis Drugs Market Share by Product
Table Middle East and Africa Rheumatoid Arthritis Drugs Sales by End User (2014-2019) (MT)
Table Middle East and Africa Rheumatoid Arthritis Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Rheumatoid Arthritis Drugs Market Share by End User
Table AbbVie Company Details
Table AbbVie Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Amgen Company Details
Table Amgen Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Amgen Recent Development
Table Bayer Company Details
Table Bayer Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Bayer Recent Development
Table Biogen Company Details
Table Biogen Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Biogen Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Johnson and Johnson Company Details
Table Johnson and Johnson Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Johnson and Johnson Recent Development
Table Merck Company Details
Table Merck Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Mitsubishi Tanabe Pharma Company Details
Table Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2014-2019)
Table Mitsubishi Tanabe Pharma Recent Development
Table Novartis Company Details
Table Pfizer Company Details
Table UCB S.A Company Details
Table Global Rheumatoid Arthritis Drugs Sales Forecast by Regions 2019-2025 (MT)
Table Global Rheumatoid Arthritis Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Rheumatoid Arthritis Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Rheumatoid Arthritis Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Rheumatoid Arthritis Drugs Sales Forecast by Product 2019-2025 (MT)
Table Global Rheumatoid Arthritis Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Rheumatoid Arthritis Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Rheumatoid Arthritis Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Rheumatoid Arthritis Drugs Sales Forecast by End User 2019-2025 (MT)
Table Global Rheumatoid Arthritis Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure North America Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Europe Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Asia Pacific Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Central & South America Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Rheumatoid Arthritis Drugs Sales Growth Rate Forecast (2019-2025) (MT)
Figure Middle East and Africa Rheumatoid Arthritis Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Rheumatoid Arthritis Drugs Value Chain
Table Rheumatoid Arthritis Drugs Customers List
Table Rheumatoid Arthritis Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
関節リウマチ用薬の世界市場：インサイト・予測 Rheumatoid arthritis can be difficult to diagnose in its early stages because the early signs and symptoms mimic those of many other diseases. There is no one blood test or physical finding to confirm the diagnosis.The global Drugs for Rheumatoid Arthritis market is valued at xx million US$ in 2018 …- 関節リウマチ治療薬の世界市場：市場規模・現状・予測 In 2018, the global Rheumatoid Arthritis Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Rheumatoid Arthritis Therapeutics status, future forecast, growth opportunity, ke…
- 生物学的治療薬の世界市場：インサイト・予測 Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural s…
- タイサブリ薬の世界市場：インサイト・予測 Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this con…
- 抗肥満処方薬の世界市場：インサイト・予測 Growing demand for obesity is one of the recent trends in the global Anti-Obesity Prescription Drugs market. Moreover, this trend is further anticipated to drive the global Anti-Obesity Prescription Drugs market over the forecast period. Furthermore, growing obesity due unhealthy food and lifestyle …